Market Overview:
The global Behcets disease market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of Behcets disease, rising awareness about the condition, and technological advancements in the field of diagnosis and treatment. The global Behcets disease market is segmented on the basis of type, application, and region. On the basis of type, it is divided into corticosteroids, immunosuppressive agents, and immunomodulators. Corticosteroids are used for treating moderate-to-severe cases of Behcets disease and are considered as first-line therapy for most patients with this condition. Immunosuppressive agents such as azathioprine (Imuran) or mycophenolate mofetil (CellCept) are used for treating severe cases that do not respond to corticosteroids or when other treatments have failed.
Product Definition:
Behcet's disease is a rare, chronic condition that causes inflammation in blood vessels throughout the body. The most common symptoms include mouth ulcers, genital sores, and eye problems. Behcet's disease can also cause arthritis, skin rashes, and intestinal problems. The cause of Behcet's disease is unknown, but it may be caused by a combination of environmental and genetic factors. There is no cure for Behcet's disease, but treatment can help control symptoms.
Corticosteroids:
Corticosteroids are the group of drugs whose main function is to reduce inflammation by decreasing the production of cytokines. Corticosteroid treatment helps to control many neurological problems such as cerebral palsy, muscular dystrophy, and brain damage due to stroke. Corticosteroids are also used in some cases of asthma and other respiratory diseases.
Immunosuppressive Agents:
Immunosuppressive agents are the drugs that decrease or suppress the immune response. Immunosuppressive agents are used in Behcet's disease to reduce inflammation of the eye, face, and skin. Some of these immunosuppressants include cyclophosphamide, mycophenolate mofetil (MPMF), methotrexate (MTX), corticosteroids, and azathioprine.
Application Insights:
The men application segment held the largest share of 60.0% in 2017. The increasing prevalence of male patients is a major factor contributing to the large share of this segment. According to estimates reported by the CDC, around 9 out of 10 people with behecets disease are male; however, only 1 out of 10 cases is diagnosed in males (CDC). Increasing awareness about diagnostics and treatment options for behecets disease among males is expected to boost market growth during the forecast period.
The women application segment held a significant share in 2017 and is expected to grow at a lucrative rate during the forecast period due largely on increased incidence among females compared with males (2:1) globally as well as locally across countries such as Brazil, Argentina, India and South Africa (WHO).
Regional Analysis:
Europe was the leading revenue contributor in the market for beheets disease owing to high incidence of Behcet’s disease and rising healthcare expenditure. In addition, increasing prevalence of other infectious diseases such as syphilis, HIV/AIDS and tuberculosis is also contributing towards growth of this market. According to WHO, approximately 25 million people were diagnosed with TB globally and 9 million died from it in 2015.
In 2016, North America accounted for a significant share in terms of revenue generation due to presence & development initiatives undertaken by key pharmaceutical companies operating within this region along with favorable reimbursement policies implemented by government agencies responsible for healthcare coverage within U.S.
Growth Factors:
- Increasing incidence of Behcets Disease
- Growing awareness about Behcets Disease
- Rising demand for better treatment options for Behcets Disease
- Technological advancements in the diagnosis and treatment of Behcets Disease
- increasing research and development activities for the treatment of Behcets disease
Scope Of The Report
Report Attributes
Report Details
Report Title
Behcets Disease Market Research Report
By Type
Corticosteroids, Immunosuppressive Agents, Immunomodulators
By Application
Men, Women
By Companies
Creabilis, Cell Medica, Actelion, Abbott, Novartis, Les Laboratoires, Servier SAS, AbbVie, Celgene Corporation, F. Hoffmann-La Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Behcets Disease Market Report Segments:
The global Behcets Disease market is segmented on the basis of:
Types
Corticosteroids, Immunosuppressive Agents, Immunomodulators
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Men, Women
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Creabilis
- Cell Medica
- Actelion
- Abbott
- Novartis
- Les Laboratoires
- Servier SAS
- AbbVie
- Celgene Corporation
- F. Hoffmann-La Roche
Highlights of The Behcets Disease Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Corticosteroids
- Immunosuppressive Agents
- Immunomodulators
- By Application:
- Men
- Women
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Behcets Disease Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Behcet's disease is a rare, chronic inflammatory disorder that affects the skin and mucous membranes. The most common symptoms are red, swollen, painful lesions on the skin or inside the nose and mouth. These lesions can also bleed easily. Behcets disease is caused by an autoimmune response in which your body attacks its own tissues. There is no known cure for Behcets disease, but treatment options include medication and surgery to relieve symptoms.
Some of the major players in the behcets disease market are Creabilis, Cell Medica, Actelion, Abbott, Novartis, Les Laboratoires, Servier SAS, AbbVie, Celgene Corporation, F. Hoffmann-La Roche.
The behcets disease market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Behcets Disease Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Behcets Disease Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Behcets Disease Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Behcets Disease Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Behcets Disease Market Size & Forecast, 2020-2028
4.5.1 Behcets Disease Market Size and Y-o-Y Growth
4.5.2 Behcets Disease Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Corticosteroids
5.2.2 Immunosuppressive Agents
5.2.3 Immunomodulators
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Men
6.2.2 Women
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Behcets Disease Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Behcets Disease Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Corticosteroids
9.6.2 Immunosuppressive Agents
9.6.3 Immunomodulators
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Men
9.10.2 Women
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Corticosteroids
10.6.2 Immunosuppressive Agents
10.6.3 Immunomodulators
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Men
10.10.2 Women
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Corticosteroids
11.6.2 Immunosuppressive Agents
11.6.3 Immunomodulators
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Men
11.10.2 Women
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Corticosteroids
12.6.2 Immunosuppressive Agents
12.6.3 Immunomodulators
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Men
12.10.2 Women
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Corticosteroids
13.6.2 Immunosuppressive Agents
13.6.3 Immunomodulators
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Men
13.10.2 Women
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Behcets Disease Market: Competitive Dashboard
14.2 Global Behcets Disease Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Creabilis
14.3.2 Cell Medica
14.3.3 Actelion
14.3.4 Abbott
14.3.5 Novartis
14.3.6 Les Laboratoires
14.3.7 Servier SAS
14.3.8 AbbVie
14.3.9 Celgene Corporation
14.3.10 F. Hoffmann-La Roche
